ASH: Johnson & Johnson's fast-growing Darzalex lines up for 2nd front-line myeloma OK

4th December 2018 Uncategorised 0

Johnson & Johnson’s Darzalex made multiple myeloma history in May when it became the first monoclonal antibody to score an FDA approval in newly diagnosed patients. And now, armed with a new batch of data, it’s looking for a repeat.

More: ASH: Johnson & Johnson's fast-growing Darzalex lines up for 2nd front-line myeloma OK
Source: fierce